BioPharm News

Jun 20, 2018
By BioPharm International Editors
The company has resubmitted a biologics license application to FDA for its proposed biosimilar to Roche’s Herceptin.
Jun 20, 2018
Legislators have requested that FDA do more to prevent drug shortages.
Jun 15, 2018
By BioPharm International Editors
Researchers at the National Cancer Institute have developed a new approach to immunotherapy that led to the complete regression of breast cancer in a patient who was unresponsive to all other treatments.
Jun 14, 2018
By BioPharm International Editors
FDA Commissioner Scott Gottlieb, MD, released a statement on new agency efforts to involve the patient voice in medical product development and FDA regulatory decision-making.
Jun 14, 2018
By BioPharm International Editors
Microbiologists from the University of Connecticut have pinpointed exterior proteins on syphilis-causing bacteria that could serve as vaccine targets for syphilis.
Jun 13, 2018
By BioPharm International Editors
Alexion Pharmaceuticals and Complement Pharma will partner to develop a preclinical C6 complement inhibitor to treat neurodegenerative disorders.
Jun 13, 2018
By BioPharm International Editors
WuXi Biologics will invest $60 million to establish a biologics production facility in Massachusetts.
Jun 13, 2018
By BioPharm International Editors
The companies will partner in research for HIV and hepatitis B immunotherapies, and Hookipa will manufacture arenavirus-based vectors for clinical development by Gilead.
Jun 13, 2018
By BioPharm International Editors
Bayer completed its acquisition of Monsanto, the largest in Bayer’s history.
Jun 12, 2018
By BioPharm International Editors
Siemens will become a preferred supplier for Sartorius Stedim Biotech’s automation solutions, and SSB will create a globally standardized automation platform for its biopharmaceutical manufacturing systems.
native1_300x100
lorem ipsum